We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Highlights Latest Innovations in Molecular Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2025

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is participating in ADLM 2025, where the company is exhibiting its latest innovations in molecular diagnostics, along with its fast and reliable solutions for key infectious threats.

At this year’s ADLM, Bioperfectus is showcasing the SSP-GL01A fully automated NGS library preparation system that provides a flexible, fully-automated solution to standardized NGS library preparation. The easy-to-use system effectively reduces turnaround time and frees up laboratory staff, minimizing manual error and enhancing efficiency.

Bioperfectus is also highlighting SAW-48, its seamless sample-to-PCR solution that integrates cutting-edge mechanical, electronic, and software technologies. SAW-48 integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument. The typical run duration is less than 45 minutes for 1-48 samples. Based on experienced magnetic separation technology, SAW-48 provides high-throughput automation combined with high performance. Also featuring at the show is the SSNP-2000B nucleic acid extraction system, which integrates new technologies such as machine, electricity, and computer software to enable automatic nucleic acid extraction of a maximum of 32 samples at one time.

Additionally, Bioperfectus is presenting its rapid diagnostic solutions for key infectious threats such as respiratory infections, Mpox (monkeypox), and vector-borne diseases. BioPerfectus offers a comprehensive flu diagnostic test portfolio ranging from POCT to Real-time PCR kits, ensuring labs have the tools to combat influenza viruses when they matter most. This includes the Allfastra SARS-CoV-2 / FluA / FluB / RSV Real Time PCR Kit, Respiratory Virus Panel (7) Real Time PCR Kit, Influenza A&B Rapid Test Kit, and Influenza Virus A/Influenza Virus B/H1N1 (2009)/ H3 Real Time PCR Kit (RUO). Bioperfectus is also highlighting its Monkeypox Virus Genotyping Real Time PCR Kit, an in vitro diagnostic test based on real-time PCR technology for the detection and identification of DNA from the West African clade and the Congo Basin (Central African) clade of Monkeypox virus.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Platelet Function Analyzer
PL-12
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.